Clinical trial
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
NCT03114033 is registered in ClinicalTrials.gov with Australian and New Zealand Intensive Care Research Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
- Lead sponsor
- Australian and New Zealand Intensive Care Research Centre
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 15, 2018
- Completion date
- December 31, 2022
- Enrollment
- 1,700 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.